Autonomix Medical Inc (AMIX)
Autonomix Medical Inc. is a development-stage medical device company listed on the NASDAQ under the ticker AMIX. The company is focused on technologies designed to sense and treat disorders of the peripheral nervous system. Its platform features a catheter-based, microchip-enabled sensing array intended to detect and distinguish peripheral neural signals. Autonomix is also developing applications for pancreatic cancer patients, as well as potential uses in chronic pain management, hypertension, cardiovascular conditions, and other nerve-related disorders. Incorporated in 2014, the company is headquartered in The Woodlands, Texas.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-AMIX
|
$4.92
|
16.8% Upside
|
Fair
|
$58.80 1,296.7% Upside
|
Not available
|
Bargain
|
Weak
|
0.0%
|
November 9, 2026
|
1.3x
|
4.088 M
|
628.091 K
|
0.0%
|
92.9%
|
-34.1
|
82.2%
|
